DK1012186T3 - Keratinocyt-vækstfaktorer og anvendelser deraf - Google Patents

Keratinocyt-vækstfaktorer og anvendelser deraf

Info

Publication number: DK1012186T3
Authority: DK; Denmark
Prior art keywords: growth factors; keratinocyte growth; keratinocyte; relates; present
Prior art date: 1996-12-06

Application number

DK97953157T

Other languages

English (en)

Inventor

Catherine L Farrell

Yue-Sheng Li

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-06

Filing date

1997-12-08

Publication date

2002-11-04

1997-12-08 Application filed by Amgen Inc filed Critical Amgen Inc

2002-11-04 Application granted granted Critical

2002-11-04 Publication of DK1012186T3 publication Critical patent/DK1012186T3/da

Links

239000003102 growth factor Substances 0.000 title abstract 2
210000002510 keratinocyte Anatomy 0.000 title abstract 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Cosmetics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK97953157T 1996-12-06 1997-12-08 Keratinocyt-vækstfaktorer og anvendelser deraf DK1012186T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US3253396P	1996-12-06	1996-12-06
US6207497P	1997-10-15	1997-10-15
PCT/US1997/022735 WO1998024813A2 (en)	1996-12-06	1997-12-08	Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives

Publications (1)

Publication Number	Publication Date
DK1012186T3 true DK1012186T3 (da)	2002-11-04

Family

ID=26708564

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97953157T DK1012186T3 (da)	1996-12-06	1997-12-08	Keratinocyt-vækstfaktorer og anvendelser deraf

Country Status (10)

Country	Link
EP (1)	EP1012186B1 (da)
JP (1)	JP4091988B2 (da)
AT (1)	ATE220689T1 (da)
AU (1)	AU5696298A (da)
CA (1)	CA2272854C (da)
DE (1)	DE69714085T2 (da)
DK (1)	DK1012186T3 (da)
ES (1)	ES2181054T3 (da)
PT (1)	PT1012186E (da)
WO (1)	WO1998024813A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
CA2289652C (en) *	1997-05-16	2012-02-28	1149336 Ontario Inc.	Methods of enhancing functioning of the upper gastrointestinal tract
US6248725B1 (en)	1999-02-23	2001-06-19	Amgen, Inc.	Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
US7186683B2 (en)	2000-09-18	2007-03-06	Sanos Bioscience A/S	Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
US7371721B2 (en)	2000-09-18	2008-05-13	Sanos Bioscience A/S	Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
EP1970072A1 (en) *	2000-09-18	2008-09-17	Sanos Bioscience A/S	Use of GLP-2 peptides for the treatment of hyperparathyroidism
DK1360202T3 (da)	2001-02-16	2008-09-22	Conjuchem Biotechnologies Inc	Langvarigt glucagon-lignende peptid 2 (GLP-2) til behandling af gastrointestinale sygdomme og lidelser
AU2002326742B2 (en) *	2001-08-21	2007-05-31	Novartis Vaccines And Diagnostics, Inc.	KGF polypeptide compositions
AU2007214362B2 (en) *	2001-08-21	2009-11-26	Novartis Vaccines And Diagnostics, Inc.	KGF polypeptide compositions
AU2005317166B2 (en) *	2004-12-15	2009-09-10	Biovitrum Ab (Publ)	Therapeutic formulations of keratinocyte growth factor
RU2016117275A (ru)	2013-11-01	2017-12-04	Сфериум Биомед С.Л.	Тельца включения для трансдермальной доставки терапевтических и косметических средств
MX2018013546A (es) *	2016-05-06	2019-04-22	Phasebio Pharmaceuticals Inc	Proteinas de fusion de elp para liberacion controlada y sostenida.

1997
- 1997-12-08 EP EP97953157A patent/EP1012186B1/en not_active Expired - Lifetime
- 1997-12-08 PT PT97953157T patent/PT1012186E/pt unknown
- 1997-12-08 AU AU56962/98A patent/AU5696298A/en not_active Abandoned
- 1997-12-08 JP JP52589498A patent/JP4091988B2/ja not_active Expired - Fee Related
- 1997-12-08 DK DK97953157T patent/DK1012186T3/da active
- 1997-12-08 AT AT97953157T patent/ATE220689T1/de active
- 1997-12-08 DE DE69714085T patent/DE69714085T2/de not_active Expired - Lifetime
- 1997-12-08 ES ES97953157T patent/ES2181054T3/es not_active Expired - Lifetime
- 1997-12-08 WO PCT/US1997/022735 patent/WO1998024813A2/en not_active Ceased
- 1997-12-08 CA CA002272854A patent/CA2272854C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2272854C (en)	2004-02-10
CA2272854A1 (en)	1998-06-11
DE69714085T2 (de)	2002-11-14
EP1012186A2 (en)	2000-06-28
WO1998024813A2 (en)	1998-06-11
JP4091988B2 (ja)	2008-05-28
WO1998024813A3 (en)	1998-08-06
ES2181054T3 (es)	2003-02-16
DE69714085D1 (de)	2002-08-22
JP2001510333A (ja)	2001-07-31
AU5696298A (en)	1998-06-29
PT1012186E (pt)	2002-12-31
ATE220689T1 (de)	2002-08-15
EP1012186B1 (en)	2002-07-17

Publication	Publication Date	Title
DE69725567D1 (de)	2003-11-20	Haltetransplantat
EP0918787A4 (en)	2001-10-04	COMPOSITIONS AND METHODS FOR ANTISENSE INHIBITION OF PROTEIN TRANSLATION
BR9703077A (pt)	1998-11-10	Compressor linear
FI101767B1 (fi)	1998-08-31	Paarit
DE69431006D1 (de)	2002-08-29	Abschneidung des Farbtonbereichs
ID24669A (id)	2000-07-27	Turunan-turunan dolastatin 15
EP1012266A4 (en)	2004-04-28	GALECTIN 8, 9, 10 AND 10SV.
FR2717697B1 (fr)	1999-02-12	Instrument d'implantation.
DK0901488T3 (da)	2003-03-03	2,4-diaminopyrimidinderivater
DE69709353D1 (de)	2002-01-31	Dichtungsanordnungen
DK1012186T3 (da)	2002-11-04	Keratinocyt-vækstfaktorer og anvendelser deraf
FI970183A7 (fi)	1997-01-16	Mikrobimenetelmä
NO992059D0 (no)	1999-04-29	2-metoksyfenylpiperazinderivater
DK0929299T3 (da)	2004-02-16	Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
BG100248A (bg)	1996-07-31	Инхибитори на скваленсинтетаза
DE59710481D1 (de)	2003-10-02	Mikroskop
FR2747908B1 (fr)	1998-12-04	Suture irrigatrice
EP0956292A4 (en)	2003-07-30	CONANTOKINES
FR2724315B1 (fr)	1997-04-04	Brancard perfectionne
NO991735D0 (no)	1999-04-13	Vaskemiddelblanding
TR199801087T2 (xx)	1998-09-21	4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il
NO991123D0 (no)	1999-03-08	25-metylen- og 24,25-epoksy-marcfortiner og paraherkamider
SE9601982D0 (sv)	1996-05-24	Tifaret 6
ITRC940012V0 (it)	1994-12-12	G.f.v. 95
SE9604295D0 (sv)	1996-11-22	Ma 3002